Friday, 03 April 2020

Korea News

  • Pfizer trial of cancer drug INLYTA is a failure

    Korea |  News | By BioSpectrum Bureau  | 0 Comment | 22 Oct, 2012

    Singapore: Pfizer has revealed that its phase III study of INLYTA (axitinib) did not meet the primary endpoint of demonstrating statistically significantly longer progression-free survival ...Read more

  • Korea to improvise Jordan healthcare system

    Korea |  News | By BioSpectrum Bureau  | 0 Comment | 07 Jul, 2014

    Singapore: Korean International Cooperation Agency (KOICA) signed a memorandum of understanding with the Ministry of Health for establishment and expansion of health centers in Jordan. The ...Read more

  • Malaysian firm Duopharma forays into biosimilars

    Korea |  News | By BioSpectrum Bureau  | 0 Comment | 01 Aug, 2012

    Singapore: Malaysia's chemical company Duopharma has tied up with Korea's PanGen Biotech to pioneer a clinical trial of Erythropoietin (EPO) in Malaysia to treat end stage renal failure pat...Read more

  • AstraZeneca, KHIDI setup cancer research program

    Korea |  News | By BioSpectrum Bureau  | 0 Comment | 11 Mar, 2014

    Singapore: AstraZeneca signed a memorandum of understanding (MoU) with the Korea Health Industry Development Institute (KHIDI) to set up an oncology research programme. AstraZeneca will pro...Read more

  • US biosimilars market to be $9 bn by 2020

    Korea |  News | By BioSpectrum Bureau  | 0 Comment | 03 Oct, 2012

    Singapore: A new report by global business intelligence firm GBI Research has highlighted that the massive potential for pharmaceuticals in the US means that the country's biosimilars marke...Read more

  • Will RNL stem cell drug trial get Korean FDA nod?

    Korea |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 12 Feb, 2013

    Singapore: RNL Bio filed an Investigational New Drug (IND) application with the Korean Food and Drug Administration (KFDA) to start phase II and III clinical trials of RNL-Astrostem stem ce...Read more

  • Samsung to make Roche biologics at Korean plant

    Korea |  News | By BioSpectrum Bureau  | 0 Comment | 24 Oct, 2013

    Singapore: Samsung BioLogics and Roche have entered into a long term strategic manufacturing agreement under which Samsung will manufacture Roche's proprietary commercial biologic medicines...Read more

  • RNL to license stem cell technology to in Turkey

    Korea |  News | By BioSpectrum Bureau  | 0 Comment | 14 Sep, 2012

    Singapore: RNL Bio has signed the agreement with RST Biomedikal Sanayi, a Turkish company, to license RNL Bio's stem cell technology. RST as a licensee will pay the $5 million fee upfront ...Read more

  • Stem cells can help prevent Alzheimer's disease

    Korea |  News | By BioSpectrum Bureau  | 0 Comment | 27 Sep, 2012

    Singapore: In the first study of its kind, researchers at one of Korea's leading university and the RNL Bio Stem Cell Technology Institute have found that adult stem cells may not only have...Read more

  • F&S: Medical devices market highly fragmented

    Korea |  News | By BioSpectrum Bureau  | 0 Comment | 11 Dec, 2012

    Singapore: A new analysis from Frost & Sullivan, titled Medical Devices Distributor Profiling in Vietnam, Indonesia, Thailand and South Korea (VITSK), revealed that the medical devices ...Read more

  • BSA-CMR Survey: Oncology is the top therapeutic focus area for CROs in APAC

    Korea |  Analysis | By BioSpectrum Bureau  | 0 Comment | 18 Sep, 2013

    The fifth edition of the annual BioSpectrum Asia Pacific clinical research organization (CRO) Survey, which is conducted in association with CyberMedia Research (CMR), yet again identifie...Read more

  • Stem cell hope for Parry-Romberg syndrome patients

    Korea |  News | By BioSpectrum Bureau  | 1 Comment | 31 Aug, 2012

    Singapore: Scientists of the RNL Stem Cell Technology Institute, Korea,  transplanted own stem cells of patients suffering from Parry-Romberg syndrome, thus dramatically improving the abil...Read more

  • Korea gearing up for biggest health convention

    Korea |  News | By BioSpectrum Bureau  | 0 Comment | 14 May, 2014

    Singapore: Even as big and emerging names continue to tie up with Korea's biggest international health convention, the event is all set to roll out the best achievements of the industry ove...Read more

  • INC Research expands in Korea to meet local demand

    Korea |  News | By BioSpectrum Bureau  | 0 Comment | 18 Sep, 2012

    Singapore: INC Research, a therapeutically focused clinical research organization (CRO) with a trusted process for delivering reliable results, opened a facility in South Korea to manage t...Read more

  • Taejoon eyes Korea top 10 list

    Korea |  Influencers | By BioSpectrum Bureau  | 0 Comment | 16 May, 2012

    Established in 1978, Taejoon Pharm has been a leading specialty pharma company in Korea in ophthalmology, contrast media and other sectors of the gastrointestinal area. Since 2002, the comp...Read more

  • Covidien gifts Korea a $21 mn medtech R&D center

    Korea |  News | By BioSpectrum Bureau  | 0 Comment | 29 Aug, 2013

    Singapore: Medical device developer, Covidien, has launched Covidien Center of Innovation Korea (CCI Korea), its first R&D, training and education center in Korea. With a total investme...Read more

  • BSA-CMR Survey: India, China lead in APAC CRO sector

    Korea |  Analysis | By BioSpectrum Bureau  | 0 Comment | 18 Sep, 2013

    The fifth edition of the annual BioSpectrum Asia Pacific clinical research organization (CRO) Survey, which is conducted in association with CyberMedia Research (CMR), yet again identifie...Read more

  • Yaskawa Electric invests in ReWalk exoskeleton

    Korea |  News | By BioSpectrum Bureau  | 0 Comment | 03 Oct, 2013

    Singapore: Israel-based ARGO Medical Technologies has partnered with innovative robotics experts Yaskawa Electric, Japan, as it continues the global expansion of its ReWalk exoskeleton devi...Read more